Dongwha Pharm.Co.,Ltd (KRX:000020)

Dongwha Pharm.Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18,971	25,656	72,317	34,347	60,480	58,596
Short-Term Investments	12,300	9,331	7,264	47,820	54,800	55,100
Trading Asset Securities	8,383	8,509	9,249	25,527	6,230	6,634
Cash & Short-Term Investments	39,654	43,497	88,830	107,695	121,510	120,331
Cash Growth	-48.14%	-51.03%	-17.52%	-11.37%	0.98%	0.26%
Accounts Receivable	78,440	78,535	64,745	61,194	56,291	57,697
Other Receivables	25,351	21,979	9,622	5,491	4,803	4,052
Receivables	103,791	100,514	74,368	66,795	61,093	61,752
Inventory	92,158	89,329	70,697	46,784	36,244	39,504
Prepaid Expenses	2,283	2,474	1,912	843.38	403.11	292.91
Other Current Assets	2,197	1,992	1,893	5,411	948.43	863.85
Total Current Assets	240,083	237,806	237,700	227,527	220,199	222,743
Property, Plant & Equipment	228,633	219,546	188,330	151,153	142,851	130,951
Long-Term Investments	60,156	65,942	72,647	54,847	50,616	48,774
Goodwill	24,931	24,931	24,931	4,556	4,556	4,556
Other Intangible Assets	58,176	58,754	25,095	11,147	13,582	12,417
Long-Term Deferred Tax Assets	9,177	8,623	6,242	6,400	6,194	3,966
Other Long-Term Assets	3,989	4,034	3,575	5,507	9,807	10,401
Total Assets	625,144	619,635	558,520	461,136	447,804	433,808
Accounts Payable	43,012	38,865	31,412	22,232	17,119	18,522
Accrued Expenses	10,227	13,818	13,601	12,032	10,445	9,085
Short-Term Debt	34,628	31,330	14,670	2,500	4,500	9,800
Current Portion of Leases	6,484	5,864	4,547	2,120	1,918	1,814
Current Income Taxes Payable	4,164	4,160	2,224	2,932	4,481	6,234
Current Unearned Revenue	-	-	4.67	-	-	-
Other Current Liabilities	37,931	38,820	38,520	32,592	26,843	20,885
Total Current Liabilities	136,446	132,857	104,980	74,408	65,307	66,340
Long-Term Debt	44,465	44,500	16,128	477.13	3,460	-
Long-Term Leases	18,228	15,295	11,756	1,567	1,596	4,075
Long-Term Unearned Revenue	-	-	-	22.87	40.47	-
Long-Term Deferred Tax Liabilities	4,014	4,130	4,592	2,096	2,703	2,476
Other Long-Term Liabilities	14,046	13,917	13,014	2,664	2,892	2,723
Total Liabilities	226,947	216,805	154,582	81,309	86,517	89,971
Common Stock	27,931	27,931	27,931	27,931	27,931	27,931
Additional Paid-In Capital	17,849	17,757	17,757	27,545	27,545	27,069
Retained Earnings	290,069	292,330	292,251	274,356	252,712	232,628
Treasury Stock	-1,663	-1,663	-1,663	-1,965	-1,965	-2,521
Comprehensive Income & Other	35,900	37,016	35,503	36,534	40,712	46,148
Total Common Equity	370,085	373,371	371,780	364,400	346,935	331,256
Minority Interest	26,958	28,304	31,004	14,273	13,198	11,427
Shareholders' Equity	398,197	402,829	403,938	379,828	361,288	343,837
Total Liabilities & Equity	625,144	619,635	558,520	461,136	447,804	433,808
Total Debt	103,805	96,989	47,100	6,664	11,474	15,689
Net Cash (Debt)	-64,151	-53,492	41,730	101,031	110,036	104,642
Net Cash Growth	-	-	-58.70%	-8.18%	5.15%	-7.49%
Net Cash Per Share	-2183.18	-1929.88	1507.27	3650.06	3981.90	3788.46
Filing Date Shares Outstanding	34.33	27.72	27.72	27.68	27.68	27.61
Total Common Shares Outstanding	34.33	27.72	27.72	27.68	27.68	27.61
Working Capital	103,637	104,950	132,721	153,119	154,892	156,404
Book Value Per Share	10779.75	13470.37	13412.96	13165.17	12534.17	11998.65
Tangible Book Value	286,979	289,686	321,754	348,698	328,797	314,283
Tangible Book Value Per Share	8359.06	10451.23	11608.15	12597.87	11878.87	11383.87
Land	60,650	60,650	60,720	58,691	59,118	56,062
Buildings	122,554	122,036	116,422	110,623	111,571	111,573
Machinery	116,506	116,010	113,504	98,257	93,686	87,590
Construction In Progress	69,386	62,495	33,906	23,896	13,628	4,983

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.